NDC 71335-2130 – Desvenlafaxine

Desvenlafaxine Succinate 25 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC71335-2130

Product details

Brand name
Desvenlafaxine
Generic name
Desvenlafaxine Succinate
Labeler
Bryant Ranch Prepack
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA204003
Marketed since
November 28, 2018
Listing expires
December 31, 2026
Pharmacologic class
Serotonin and Norepinephrine Reuptake Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Desvenlafaxine →

Package NDC codes (4)

Package NDCDescriptionSince
71335-2130-130 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2130-1)Jul 19, 2022
71335-2130-260 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2130-2)Mar 13, 2023
71335-2130-390 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2130-3)Nov 1, 2024
71335-2130-4120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-2130-4)Nov 1, 2024

Other Desvenlafaxine products